Suppr超能文献

导管定向取栓术与手术取栓术治疗中高危肺栓塞的疗效:一项回顾性观察研究。

Outcomes of catheter-directed embolectomy and surgical embolectomy for intermediate- to high-risk pulmonary embolism: a retrospective observational study.

作者信息

Baloch Hafiza Noor Ul Ain, Ishisaka Yoshiko, Lookstein Robert, Lattouf Omar, Ehrlich Madeline, Acquah Samuel, Bahk Jeeyune, Rehman Abdul, Shapiro Janet, Steiger David

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai Health System, New York City, NY, USA.

Department of Medicine, Icahn School of Medicine at Mount Sinai Health System, New York City, NY, USA.

出版信息

Curr Med Res Opin. 2025 Apr;41(4):713-720. doi: 10.1080/03007995.2025.2494639. Epub 2025 Apr 28.

Abstract

OBJECTIVE

Intermediate risk (IR)- and high risk (HR)-pulmonary embolism (PE) are associated with mortality rates that span 1.8% to 17% and greater than 31% respectively. Catheter-directed embolectomy (CDE) and surgical embolectomy (SE) for IR- and HR-PE offer alternatives to systemic thrombolysis, but data comparing CDE versus SE is limited. We assessed the outcomes of patients with acute PE who received CDE or SE for IR- and HR-PE.

METHODS

A retrospective review of all adult patients who had undergone CDE or SE for IR- and HR-PE in the Mount Sinai Health System between August, 2019 to June, 2022 was performed. Fisher's exact test and Student's -test (or Mann-Whitney U-test) were used for comparing qualitative and quantitative outcomes respectively between the CDE and SE groups.

RESULTS

Fifteen (15) patients received SE, and 25 patients received CDE. Patients who received SE included 53% IR- and 47% HR-PE, while those who received CDE included 60% IR- and 40% HR-PE. CDE and SE had 96% and 100% technical success rates respectively. The 30-day all-cause mortality rates were 13.3% and 8% in the SE and CDE groups respectively ( > 0.05). The rates of major hemorrhagic complications in the CDE and SE groups were 4% and 26.7% respectively ( > 0.05).

CONCLUSION

CDE and SE were associated with high technical success rates in patients with IR- and HR-PE along with a low risk of major complications and acceptable 30-day all-cause mortality rates. In the absence of significant contraindications, CDE may provide a less invasive alternative to SE.

摘要

目的

中危(IR)和高危(HR)肺栓塞(PE)的死亡率分别为1.8%至17%和超过31%。针对IR-PE和HR-PE的导管定向取栓术(CDE)和外科取栓术(SE)为全身溶栓提供了替代方案,但比较CDE与SE的数据有限。我们评估了接受CDE或SE治疗IR-PE和HR-PE的急性PE患者的结局。

方法

对2019年8月至2022年6月在西奈山医疗系统接受CDE或SE治疗IR-PE和HR-PE的所有成年患者进行回顾性研究。分别采用Fisher精确检验和Student's t检验(或Mann-Whitney U检验)比较CDE组和SE组的定性和定量结局。

结果

15例患者接受了SE,25例患者接受了CDE。接受SE的患者中,IR-PE占53%,HR-PE占47%;而接受CDE的患者中,IR-PE占60%,HR-PE占40%。CDE和SE的技术成功率分别为96%和100%。SE组和CDE组的30天全因死亡率分别为13.3%和8%(P>0.05)。CDE组和SE组的大出血并发症发生率分别为4%和26.7%(P>0.05)。

结论

CDE和SE在IR-PE和HR-PE患者中技术成功率高,主要并发症风险低,30天全因死亡率可接受。在无重大禁忌证的情况下,CDE可能为SE提供一种侵入性较小的替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验